OREX Financial Facts

Research and development: 10.72M
Total revenues: 30.86M
See Full Income Statement

Commitments and contingencies: 0
Total liabilities and stockholders' equity: 154.48M
See Full Balance Sheet

Orexigen Therapeutics (OREX) Earnings

  |   Expand Research on OREX
Next EPS Date 8/7/15 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate +17.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +15.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/8/15 Q115 -$0.14-$0.14 $0.00$4.36M$7.28M N/A Details
2/25/15 Q414 $0.00$0.21 -$0.21$22.95M$49.65M N/A Details
11/10/14 Q314 $0.09-$0.13 +$0.22$30.9M$8.93M N/A Details
8/7/14 Q214 -$0.21-$0.21 $0.00$857K$1M N/A Details
3/12/14 Q413 -$0.21-$0.19 -$0.02$857M$900M N/A Details
11/12/13 Q313 -$0.19-$0.18 -$0.01$857K$800K N/A Details
8/6/13 Q213 -$0.19-$0.19 $0.00N/A$900K N/A Details
3/13/13 Q412 -$0.41-$0.44 +$0.03$857K$910K N/A Details